WeightCare Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.1/10
Best for: starting below a standard dose, with microdose tiers
WeightCare falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $139 a month, paid up front; its compounded tirzepatide, at $499, is 86% above the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
WeightCare sells compounded semaglutide and tirzepatide from Fort Lauderdale, FL, and says it has served more than 85,000 members since 2022. Month to month, semaglutide is $399 and tirzepatide $499. Prepaid plans cut that to as low as $139 and $216 a month on 12 months. It names no pharmacy but says its partners are FDA-registered and PCAB-accredited, and it serves 45 states.
Is WeightCare legit?
WeightCare is a real, operating US company, and the FDA has issued it a warning letter. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate WeightCare 6.1/10 overall.
Is there a WeightCare promo or coupon code?
We know of no promo or coupon code for WeightCare. Its listed price is $139 a month. Coupon sites advertising "WeightCare discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how WeightCare compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to WeightCare
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
WeightCare at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $139/mo
- What's included
- Medication · Consult · Shipping
- Availability
- 45 states
- FDA status
- 1 FDA warning letter (details below)
How WeightCare scores
Six columns, each one computed from something WeightCare has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
0.5/10$499/month is 86% above the $269 median for compounded tirzepatide across the sellers we compare. A cheaper plan paid several months up front is also listed. A cheaper microdose or starter price is also listed; Value is scored on the standard dose.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
4.5/10The FDA has issued it a warning letter. No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
9.2/10Serves 45 of 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on WeightCare
Last checked October 2026- Checked the listed price across 11 dose or plan tiers
- Checked state coverage: 45 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for WeightCare
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with WeightCare involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1WeightCare shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask WeightCare which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $139, tirzepatide $216. That leaves out membership fees, first-month rates and insurance copays.
- WeightCare serves 45 of 50 states, so check that yours is one of them.
- The FDA has issued WeightCare a warning letter. It is covered in the enforcement section below; read what it alleges before you decide.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting WeightCare
- WeightCare offers email support
- Hours
- M-F 9AM-6PM EST
Cancelling WeightCare
Taken from the terms WeightCare publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None on the monthly plan; multi-month plans are paid up front
- Refund policy
- Full refund only before the medical questionnaire is submitted, or if a physician finds you are not a candidate
- Early-termination fee
- None
Medications WeightCare lists
WeightCare lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Month-to-month, '$399 / per month', all doses.
'$747 for 3 months of care and medication ($249/month)', all doses.
'$215 / per month', all doses.
'$139 / per month'; Affirm financing offered.
Micro-dose program, $249 a month; 3 months $597.
Month-to-month, '$499 / per month', all doses.
3-month starter; renewal $997 for 7.5 mg ($333/mo).
'$275 / per month'.
'12 MONTH PLAN (ANY DOSE) $216 / PER MONTH'.
'$1350 (for up to 15 mg/week for 12 weeks)'.
'$2150 (for up to 15 mg/week for 24 weeks)'.
Check the price yourself before you pay
Every figure here comes from WeightCare's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves 45 states
Against it
- Semaglutide costs $399 a month, 101% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $499 a month, 86% above the $269 median for compounded tirzepatide across the sellers we compare
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued WeightCare a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What WeightCare charges
WeightCare charges $139/month.
- Compounded semaglutide (monthly): $399/month
- Compounded semaglutide (3-month plan): $249/month
- Compounded semaglutide (6-month plan): $215/month
- Compounded semaglutide (12-month plan): $139/month
- Compounded semaglutide (microdose, monthly): $249/month
- Compounded tirzepatide (monthly): $499/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so WeightCare's $499 is a premium, and a premium has to buy something. Check what is bundled before you accept it. Some of WeightCare's plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
Live Vital dispenses semaglutide and tirzepatide from $130/month, which makes it the fair comparison to run before you commit here.
What WeightCare dispenses
WeightCare prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder. WeightCare also lists a microdose plan, and the published evidence on GLP-1 microdosing is letters and commentary rather than trials.
Safety and disclosure
WeightCare tells you its price before you start the medical questionnaire, the 45 states it serves, and that its pharmacy is accredited. The FDA has issued WeightCare a warning letter, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If WeightCare will not tell you, treat that as a warning sign. Across the market, the FDA's GLP-1 warning letters are mostly about what sellers said rather than what pharmacies made. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether WeightCare bills your plan before you start.
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
Our read
WeightCare costs more than the middle of this market. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. The catch is disclosure, which is why WeightCare scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Ivim Health is the nearest comparison we review, and worth reading alongside this. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
WeightCare falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $139 a month, paid up front; its compounded tirzepatide, at $499, is 86% above the $269 median among the sellers we compare.
Before you pay WeightCare
Starting at $139 a month. Check today's price, then start the intake.
Where WeightCare is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to WeightCare sets more sellers in the same category beside WeightCare on price, states and what the price includes.
Frequently Asked Questions
How to check WeightCare yourself
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- How to Read a Peptide Certificate of Analysis (and What It Cannot Prove)
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Colorado, Iowa, Missouri, Montana, Rhode Island, Tennessee, West Virginia, Wyoming and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
WeightCare has an FDA warning letter on record, dated February 20, 2026
This letter concerns false & misleading claims/misbranded. A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this WeightCare review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See WeightCare's current pricing
Plans start at $139 a month. Whether you qualify is a clinician's decision, made after your intake.